# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ulysses S. Grant (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI002-SYN-TD
- Date: 1884-07-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Corinne Batiste, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week follow-up on the day of the otolaryngology consultation and biopsy. **S**

## History of present illness

Mr. Grant returns two weeks after his first visit, on the afternoon of his otolaryngology consultation. This morning the otolaryngologist examined him with a flexible laryngoscope, which showed an ulcerated lesion of the right tonsillar pillar with a clear larynx, and took a biopsy. The pathologist's same-day frozen section shows squamous cell carcinoma; p16 staining and the final report will follow within a few days. Last week's contrast CT of the neck showed a right tonsillar mass with one enlarged right level II lymph node. His throat pain is unchanged at 5 of 10. He takes the acetaminophen solution two or three times a day and uses the lidocaine rinse when the pain is worst. He manages soft foods and liquids and has lost 1 kg in two weeks. He smoked his last cigar a week ago, on the quit date set at his first visit, and has not smoked since. Varenicline taken without food made him queasy, so he stayed on 0.5 mg twice daily for an extra week; taken after meals it no longer causes nausea. He has noticed no change in mood, sleep, or dreams. He wants a treatment plan quickly so that he can keep working on his memoir. **S**

| Element | Detail |
|---|---|
| Workup today | Flexible laryngoscopy and biopsy; frozen section shows squamous cell carcinoma, p16 and final report pending |
| Imaging | Contrast CT of the neck last week: right tonsillar mass and one enlarged right level II node |
| Pain | 5 of 10, unchanged |
| Swallowing and weight | Soft foods and liquids; down 1 kg in two weeks |
| Tobacco | No cigars for one week, since the agreed quit date |
| Varenicline tolerance | Nausea only when taken without food; no mood or sleep change |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Weight down 1 kg in two weeks; no fever or night sweats |
| Ears, nose, mouth, and throat | Positive | Right-sided throat pain and painful swallowing; no ear pain or voice change |
| Respiratory | Negative | No cough, hemoptysis, or breathlessness |
| Gastrointestinal | Negative | No nausea when varenicline is taken after meals; no vomiting |
| Psychiatric | Negative | Worried about the diagnosis and the time it may take from his writing; no low mood; sleep and dreams unchanged |

5 systems reviewed. **S**

## Current medications

- Varenicline 1 mg oral tablet, one tablet twice daily **S**
- Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain **S**
- Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat pain **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/80 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 77 kg; BMI 25.7 kg/m². All vital signs are synthetic.

Throat pain (0-10): 5. All results are synthetic.

## Change since baseline

- Throat pain (0-10): 5 at baseline, 5 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert and composed; speaks in short stretches because talking aggravates the throat pain |
| Oropharynx | Ulcerated lesion of the right tonsillar pillar with a fresh biopsy site; no active bleeding |
| Neck | Firm, nontender right level II node, as on the CT; no other nodes |
| Lungs | Clear |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Squamous cell carcinoma of the right tonsillar pillar, staging in progress** (C09.1). The frozen section from this morning's biopsy shows squamous cell carcinoma. The CT shows a right tonsillar primary with one enlarged right level II node. The p16 status and the stage are not yet known. **S**
   - PET/CT for staging next week, as ordered at the first visit.
   - Referral to the multidisciplinary head and neck oncology team as soon as the final pathology is reported.
   - Dental evaluation and a speech-language pathology swallowing baseline once the treatment plan is known, before any radiation.
   - Primary care review after staging.
2. **Nicotine dependence, cigars, one week abstinent** (F17.290). Abstinent since the agreed quit date a week ago. Varenicline is tolerated when taken after meals. **S**
   - Increase varenicline to 1 mg twice daily after meals.
   - Brief counseling today: stopping now improves treatment results and healing; remove the remaining cigars from the house.
   - A 12-week course, with a further 12 weeks if he stays abstinent, to prevent relapse.
3. **Oropharyngeal dysphagia from the tonsillar tumor** (R13.12). Pain 5 of 10, unchanged; swallowing soft foods and liquids safely. **S**
   - Continue the acetaminophen solution, no more than 3,000 mg a day, and the lidocaine rinse.
   - Wait 60 minutes after the lidocaine rinse before eating or drinking.
4. **Unintended weight loss** (R63.4). Weight 77 kg, down 1 kg (1.3 percent) from 78 kg at intake. **S**
   - Dietitian referral now, before treatment.
   - Soft, calorie-dense diet with two oral supplement drinks a day; weight at every visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Head and neck examination with flexible laryngoscopy | At diagnosis | Completed today | Done by the otolaryngologist this morning: ulcerated right tonsillar pillar lesion; larynx clear |
| Laboratory | Biopsy with pathology and p16 immunohistochemistry | At diagnosis | Completed today | Biopsy taken this morning. The frozen section shows squamous cell carcinoma; p16 and the final report are pending |
| Imaging | Contrast-enhanced CT of the neck | At diagnosis | Up to date | Done last week: right tonsillar mass with one enlarged right level II node |
| Imaging | PET/CT for staging | Once carcinoma is confirmed | Ordered | Booked for next week |
| Referral | Otolaryngology–head and neck surgery | Urgently, within two weeks of presentation | Completed today | Seen today, two weeks after presentation |
| Referral | Multidisciplinary head and neck oncology team | After tissue diagnosis | Due | Referral to follow the final pathology report within days |
| Referral | Dental evaluation before radiation | Before radiation to the neck | Due | To be booked once the treatment plan is known |
| Referral | Speech-language pathology swallowing baseline | Before treatment | Due | To be booked with the dental evaluation |
| Referral | Dietitian assessment | Before treatment | Referred | Referred today because of painful swallowing and a 1 kg weight loss |
| Examination | Weight | Every visit | Completed today | 77 kg, down 1 kg (1.3 percent) from intake |
| Survey | Throat pain score (0-10) | Every visit | Completed today | 5 of 10, unchanged from intake |
| Survey | Depression screen (PHQ-2) | Every primary care visit after the diagnosis | Deferred | Not repeated today, because the visit was taken up by the new diagnosis. This departs from the care plan. He reports no low mood; the PHQ-2 is due at the post-staging visit |
| Laboratory | CBC, basic metabolic panel, and albumin | Before and after treatment | Due | Baseline normal at intake; repeat before treatment starts, at the post-staging visit |
| Laboratory | TSH | Baseline before neck radiation, then every 6 to 12 months after it | Up to date | 1.8 mIU/L at intake |
| Self-management | Tobacco use status and cessation counseling | Every visit | Completed today | No cigars for one week; counseling given |
| Medication safety | Varenicline tolerance: nausea, sleep, mood, and behavior | Each visit during treatment | Completed today | Nausea only when taken without food; no mood, sleep, or behavior change. Dose increased to 1 mg twice daily |

## Goal progress

- Tissue diagnosis within two weeks of the first visit. Outcome by 1884-07-21: Biopsy at the otolaryngology visit two weeks after presentation. **S**
- Stop all tobacco use before treatment begins. In progress; target 1884-08-04. **S**
- Limit weight loss to less than 10% of baseline weight through treatment. In progress; target 1884-10-22. **S**
- Keep throat pain at 4 or below on the 0-10 scale most days. In progress; target 1884-10-22. **S**

## Medication changes

- Stopped: Varenicline 0.5 mg oral tablet, one tablet daily for three days, then one tablet twice daily **S**
- Started: Varenicline 1 mg oral tablet, one tablet twice daily **S**

## Guideline basis

- NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025), National Comprehensive Cancer Network
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026), Aether Forge

## Follow-up

- Telephone call with the final pathology report within a few days. PET/CT next week. Primary care visit after staging in about two weeks. **S**
- Next scheduled visit 1884-08-04: primary care visit after staging to coordinate nutrition, dental care, tobacco cessation, and symptom control before treatment. **S**
